• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning

tetano

Editor, Senior Moderator
Sci Adv


. 2025 May 30;11(22):eads7187.
doi: 10.1126/sciadv.ads7187. Epub 2025 May 28. Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning

Galen J Correy[SUP] 1 [/SUP], Moira M Rachman[SUP] 2 [/SUP], Takaya Togo[SUP] 2 [/SUP], Stefan Gahbauer[SUP] 2 [/SUP], Yagmur U Doruk[SUP] 3 [/SUP], Maisie G V Stevens[SUP] 3 [/SUP], Priyadarshini Jaishankar[SUP] 2 [/SUP], Brian Kelley[SUP] 4 [/SUP], Brian Goldman[SUP] 4 [/SUP], Molly Schmidt[SUP] 4 [/SUP], Trevor Kramer[SUP] 4 [/SUP], Dmytro S Radchenko[SUP] 5 [/SUP], Yurii S Moroz[SUP] 5 6 7 [/SUP], Alan Ashworth[SUP] 3 [/SUP], Patrick Riley[SUP] 4 [/SUP], Brian K Shoichet[SUP] 2 [/SUP], Adam R Renslo[SUP] 2 [/SUP], W Patrick Walters[SUP] 4 [/SUP], James S Fraser[SUP] 1 [/SUP]



Affiliations
Abstract

The macrodomain of severe acute respiratory syndrome coronavirus 2 nonstructural protein 3 is required for viral pathogenesis and is an emerging antiviral target. We previously performed an x-ray crystallography-based fragment screen and found submicromolar inhibitors by fragment linking. However, these compounds had poor membrane permeability and liabilities that complicated optimization. Here, we developed a shape-based virtual screening pipeline-FrankenROCS. We screened the Enamine high-throughput collection of 2.1 million compounds, selecting 39 compounds for testing, with the most potent binding with a 130 μM median inhibitory concentration (IC[SUB]50[/SUB]). We then paired FrankenROCS with an active learning algorithm (Thompson sampling) to efficiently search the Enamine REAL database of 22 billion molecules, testing 32 compounds with the most potent binding with a 220 μM IC[SUB]50[/SUB]. Further optimization led to analogs with IC[SUB]50[/SUB] values better than 10 μM. This lead series has improved membrane permeability and is poised for optimization. FrankenROCS is a scalable method for fragment linking to exploit synthesis-on-demand libraries.


 
Back
Top